Search for: "Ely v. State" Results 321 - 340 of 1,089
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Feb 2018, 7:31 am
Continued from Part IInfringement - no role for German doctrine of "deliberate selection" following Eli Lilly v Actavis, yet...On the basis of a normal interpretation, the shear mode fell within the scope of the claims. [read post]
17 Feb 2018, 7:30 am
”Henry loved when he was in "shear mode"Claim "Interpretation"  - it is all about what you say and disclaimWith the old "Construction" heading now replaced with "Interpretation", Mr Justice Carr stated he would be applying"principles concerning normal interpretation and equivalents set out by the Supreme Court in Actavis v Eli Lilly [2017] UKSC 48, [2018] and by the Patents Court in Mylan v Yeda [2017] EWHC… [read post]
6 Feb 2018, 7:24 am
Instead of veering towards such a transformation, the government decided to rely once again on its preferred model, stimulating growth through investment, exports and subsidies to state-owned enterprises (SOEs), operating outside of China on a regional scale, via BRI. [read post]
31 Jan 2018, 10:05 pm
  Article 3(a):  a spectrum of specificity The Court of Appeal reviewed the case law of the CJEU and pending references, focussing on Case C-322/10 Medeva BV v Comptroller-General of Patents, Designs and Trade Marks and Case C-493/12 Eli Lilly & Co Ltd v Human Genome Sciences Inc. [read post]
31 Jan 2018, 8:13 pm by Florian Mueller
Ragan, a discovery expert, and Orrick's Alyssa Caridis, an IP lawyer from a family of inventors.The brief notes that Qualcomm is seeking similar sanctions against other non-parties that have been told to produce documents in connection with FTC v. [read post]
29 Jan 2018, 2:57 am
 The UCL debate on the UK Supreme Court decision Actavis v Eli Lilly ("Equivalents: K = Na. [read post]
22 Jan 2018, 11:57 am by Ezra Rosser
Ely Jr., Buchanan and the Right to Acquire Property, Cumberland L. [read post]
19 Jan 2018, 3:58 am
Readers interested in patent law will be familiar with last summer's decision of the UK Supreme Court in Actavis v Eli Lilly [2017] UKSC 48. [read post]
5 Jan 2018, 11:00 am by Dan Ernst
Ely Jr., Vanderbilt University Law School, has posted Buchanan and the Right to Acquire Property, which is forthcoming in the Cumberland Law Review:This article examines the impact of the Supreme Court decision in Buchanan v. [read post]
20 Dec 2017, 1:52 pm by Harold O'Grady
Brooklyn Law School Library’s e-book collection has a great title for this time of year:  A Kosher Christmas: ‘Tis the Season to Be Jewish by Joshua Eli Plaut. [read post]
17 Dec 2017, 4:16 pm by INFORRM
  Media Law in Other Jurisdictions Australia On 15 December 2017 Chaney J handed down judgment in the case of Rayney v State of Western Australia [2017] WASC 367. [read post]
1 Dec 2017, 6:20 am
The Swiss Federal Patent court had originally denied the infringement of Eli Lilly's patent but the Supreme Court granted Eli Lilly, a remarkable event in itself. [read post]
23 Nov 2017, 9:30 pm by Sarah Madigan
Supreme Court case, Christie v. [read post]
8 Nov 2017, 10:48 pm
THE VOTE - has the decision in Actavis v Eli Lilly improved the law? [read post]
8 Nov 2017, 5:29 am
Part 2 covers claims with numerical limits, relevance of the file history, harmonisation, and a vote as to whether the decision in Actavis v Eli Lilly has improved the law. [read post]
1 Nov 2017, 5:00 am by Bruce Ackerman
United States decision to its early en banc decision in Eli Shifa v. [read post]
31 Oct 2017, 12:05 am
Limited and others v Yeda Research and Development Company Limited and others [2017] EWHC 2629 (Pat) - the first application of Actavis v Eli Lilly in the Patents Court. [read post]
19 Oct 2017, 9:55 am by David Post
” In the 2012 election, Republicans won 48.6 percent of the statewide vote, which gave them 61 percent of the seats in the state’s 99-seat assembly, and in the 2014 election, Republicans took 52 percent of the statewide vote and ended up with 64 percent of Wisconsin State Assembly seats. [read post]
17 Oct 2017, 6:09 pm
The panel members were Mattias Zigann, the presiding judge of the Munich Regional Court, Philip Kerr of Allens Linklaters and Larry Welch, the Senior Director, and Assistant General Patent Counsel at Eli Lilly and Company.Mr Ludwig explained that the question of what relief was appropriate had been highlighted by the very recent decision of the United States Court of Appeals for the Federal Circuit in AMGEN INC & ors v. [read post]